KKR-Stonepeak buyout of UK’s Assura needs clearance in China, EU
Kohlberg Kravis Roberts and Stonepeak Partners’ 1.61 billion-pound planned buyout of UK doctors’ clinics owner Assura will need antitrust clearance in China, the EU, Israel and South Korea in addition to...To view the full article, register now.
Already a subscriber? Click here to view full article